Multiple studies show that secreted AGR2 contributes to tumor growth and progression, particularly through its role in angiogenesis [114,115,116] and as a ligand for cell surface receptors, including C4.4A [117] and LYPD3 [118,119]. This evidence concerns the gene LYPD3 and neoplasm.